What development phase is Microsurgery technique for root coverage associated to EMD in?

Microsurgery technique for root coverage associated to EMD is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Microsurgery technique for root coverage associated to EMD

Rio de Janeiro State University · FDA-approved active Biologic Quality 2/100

The microsurgery technique for root coverage associated with EMD, developed by Rio de Janeiro State University, is currently marketed and holds a niche position in periodontal treatments. A key strength is the protection provided by a key composition patent, which is set to expire in 2028. The primary risk is the potential increase in competition following the patent expiry, which could erode market share.

At a glance

Generic name	Microsurgery technique for root coverage associated to EMD
Sponsor	Rio de Janeiro State University
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain® (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Microsurgery technique for root coverage associated to EMD CI brief — competitive landscape report
Microsurgery technique for root coverage associated to EMD updates RSS · CI watch RSS
Rio de Janeiro State University portfolio CI